Microsoft word - amani abou-zamzam resume ca 1-12.doc


Amani A Abou-Zamzam MBA
Email [email protected] Cell 310.780.0881 www.amani.md
EDUCATION
MBA PEPPERDINE UNIVERSITY, Malibu, Calif
Masters in Business Administration, Marketing emphasis BA UNIVERSITY OF CALIFORNIA, San Diego, Calif. Bachelors of Arts. Majors: Biochemistry & Cell Biology; Psychology *Supplemented education with scholarships & work-study program MBS-Medical Billing specialist- PRS Physician Reimbursement Systems
EXPERIENCE
West Coast Urology Executive
Myriad Genetics- Pre-Launch Strategy for West Coast Prostate Cancer KOL’s
-Identified KOL West Coast -Natl
-KOL AD Board Selection -Identified Speakers for Development
-Urology Society Networking with Urologic Oncology KOL's -AUA; WSAUA; SUO; LAU; OCU; SDU
-Advocacy- Speaker placement @ PCF
-Educational and Society Program Planning for Pre and Post launch
-Study Placement with West Coast KOL and Clinical Investigators in Urology and Prostate Arena.
-Identifying West Coast Key Accts-LUGPA Strategies and Markets

Director of Business Development
PRS Physician Reimbursement Systems
• Responsibilities include partnership negotiation with Pharma companies to implement • Aid sales force training in the use of PRS tools. • Facilitate promotion of AUA-American Urological Association, endorsed products. • Conduct PRS Urology Coding Seminars
Director of Business Development

DeSantis Management Group
• Facilitate Presentations for Westerns Section AUA Practice Management Forums • Coordinate Presenters, Sponsors and implementation for Los Angeles Urological Society
Urology Business Consultant

The Upjohn Company/Pharmacia & Upjohn/Pharmacia/Pfizer Awards and Recognition:
• 2003 #1 National Ranking #1 Market Share Penetration • 2003 Platinum Award for National Business Consultant Team • Stock Option Bonus top performers - 3 nationally Practice Management Consultant:
Consulting services for Urologists-Dermatologists Greater Los Angeles area:
Business Development -
• Physician Practice growth strategies and office efficiencies • Implemented Staff training & Development • Urology Niche market expansion: OAB and Erectile Dysfunction • Internal & External Marketing-Facilitate referral building and Outreach opportuntities
Amani A. Abou-Zamzam MBA
EXPERIENCE: Continued
Urology Business Consultant
Society and Medicare Advisor:

• Urology Society Liaison- Western Section AUA, LA Urologic, Cedars Urology, UCLA Urology, Raz Fellowship, Leach Fellowship, Male-Sexual Dysfunction and Female Sexual Dysfunction KOL’s • Facilitate Practice management, Medicare and Educational workshops for Urology and Oncology • Medicare Carrier Liaison for Pharmacia for Urology and Oncology Specialties • Achieved Medicare coverage of Caverject for state of California • Achieved extended Medicare coverage for Camptosar for Western region • Medicare billing, coding, reimbursement and compliance PRS- Physician Reimbursement Systems Account Manager/Marketing Liaison/Team Leader-Key Urology Accounts: California
Southern Cal- UCLA,Cedars-Sinai, Raz, Tower, MSD, Sansum Santa Barbara:
• Account Management responsibilities include: • Coordinate Pre and post launch activities for So Cal area for Detrol, Detrol LA, Caverject for National, Regional teams and Corporate product management • Identify KOL-Key Thought Leaders for ED and OAB for Studies, Public Relations, Promotional Programs, Society Educational programs, Consultant panels; Speaker Development • KOL Liaison for Regional Management, Product Management and Marketing to So Cal-Urology Thought Leaders for Detrol, Detrol LA and Caverject; Dermatology Thought Leaders for Rogaine • Marketing Management: Managed 800# media promotions for Caverject and Rogaine for So Cal Region- DTC Campaigns and pull-through strategies. • Caverject and Detrol/Detrol LA formulary approvals achieved at UCLA and Cedars Recruiting, Training and Coaching Teams:
• Provided training and coaching for National Consultant team and Regional reps • Assisted in the interview hiring process for National and local teams • Pioneered Mentoring committee for California Region
Health Science Associate/Hospital Sales
The Upjohn Company
• Conducted Marketing Advisory Panels, train and coached new representatives. • Assisted management in special projects and programs for the LA district including UCLA, Cedars, and • Manager Training Role. Interviewed and Trained new hires.
Hospital Sales Consultant

The Upjohn Company
• Hospital Sales responsibilities covering UCLA, Cedars-Sinai, West LA VA, LA Childrens Hospitals. Products including: Prostin VR, Atgam, Zefazone, Xanax, Halcion, Vantin, Cleocin V, Depo-Provera, Prepadil Gel & Colestid Products and entire catalog. • Achieved Hospital Formulary approvals of Colestid, Zefazone, Depo-Provera & Prepadil Gel at
Pharmaceutical Sales Specialist

• General Sales responsibilities covering the Los Angeles area including 7 community hospitals; covering South Bay, West Los Angeles and surrounding areas. Products ranging from Xanax, Halcion, Motrin, Micronase, Cleocin IV to OTC and entire catalog including hospital and independent pharmacy products. • Multiple sales awards. #2 Motrin 800 Region 1987.

Source: http://amani.md/data/uploads/AMANI%20ABOU-ZAMZAM%20RESUME%20CA%201-12.pdf

brl.ntt.co.jp

D. Bacon, A.M. Childs and W. van Dam,2005:(1) is of importance when trying to solvethe hidden subgroup problem for semi-directIt also appears in the theory cyclotomic classesans is a natural generalization of the discretelogarithm problem. We use some number theoretic results, to de-that are more efficient than the brute forcesearch (but unfortunately still exponential inWe use our classical

Microsoft word - pgx highlights-volume 4 issue 1 march 2012.doc

PGx Highlights – A PGx Focus Group Newsletter, AAPS Volume 4; Issue 1, March 2012 Highlight 1 Regulatory Affairs: New FDA Draft Guidance -2011: Clinical Pharmacogenomics: Premarketing Evaluation in Early Phase Clinical Studies E. Jane Mitchell, PhD, RAC Regulatory Operations, Optum Insight E-mail: [email protected] In February 2011, FDA published a new Draft 1. “ Ident

Copyright © 2013-2018 Pharmacy Abstracts